This matter concerns the heartburn medication Zantac. More specifically, this matter concerns the ranitidine molecule—the active ingredient of Zantac. The Judicial Panel for Multidistrict Litigation formed this MDL (number 2924) on February 6, 2020.
The following calendar lists all scheduled hearings in this MDL. Calendar activity pertaining to other cases before Judge Rosenberg is omitted from display, but all web-based calendar information is subject to change. The most accurate source for scheduled hearings is PACER.